Study Finds Widespread Problems in Reporting of Clinical Trial Results
Alexander Gaffney (Regulatory Focus)
Time, distance and the new world of online business news
John Carroll (FierceBiotech)
The Reasons for Failure at the FDA
Derek Lowe (In the Pipeline)
Behind The Scenes With Dream Team, CytRx And Galena
Richard Pearson (Mox Reports / Seeking Alpha)
The must read of the week for any biotech investor. You always knew (I hope) that not everything written online was legit, but this expose knocks it out of the park.
A DNA Sequencing Breakthrough That Many Expectant Moms Will Want
Steven Salzberg (Forbes)
UK to fast-track some drugs under early access scheme (Reuters)
Early Access to Medicines Scheme (EAMS) - official info from MHRA (Britain's "FDA")
Following up on the item in the post last week, the UK officially unveils it's cousin to the US FDA's Breakthrough Therapy designation. The documents raise as many questions as they answer, which I hope to have time to address on the blog.
Alexander Gaffney (Regulatory Focus)
Time, distance and the new world of online business news
John Carroll (FierceBiotech)
The Reasons for Failure at the FDA
Derek Lowe (In the Pipeline)
Behind The Scenes With Dream Team, CytRx And Galena
Richard Pearson (Mox Reports / Seeking Alpha)
The must read of the week for any biotech investor. You always knew (I hope) that not everything written online was legit, but this expose knocks it out of the park.
A DNA Sequencing Breakthrough That Many Expectant Moms Will Want
Steven Salzberg (Forbes)
UK to fast-track some drugs under early access scheme (Reuters)
Early Access to Medicines Scheme (EAMS) - official info from MHRA (Britain's "FDA")
Following up on the item in the post last week, the UK officially unveils it's cousin to the US FDA's Breakthrough Therapy designation. The documents raise as many questions as they answer, which I hope to have time to address on the blog.
RSS Feed
